Note: Ingredients listed on restricted chemical lists
EC/CAS
68308-54-3
Name of the chemical
Glycerides, tallow mono-, di- and tri-, hydrogenated
Concentration
N/A
General Information
Product name
Cyclosporine Capsules Finished SYNONYMS
Product name
Cyclosporine Capsules Finished SYNONYMS
Identification on the label/Trade name
Cyclic polypeptide produced THERAPEUTIC
Chemical name
Cyclic polypeptide produced THERAPEUTIC
Icons in SDS
Company Information
company name
species
Section 2
Health hazards
INFORMATION OSHA EMERGENCY CAUTION – The information in this MSDS is based on the hazards of the OVERVIEW active ingredient. While diluted, this material may present the following
SECTION 2: Hazards identification
IMMUNOSUPPRESSANT, CARCINOGEN EYE May cause irritation or permanent tissue damage. SKIN May cause irritation and contact dermatitis. INGESTION Ingestion may cause irritation. INHALATION Material may be irritating to mucous membranes and upper respiratory tract. ADVERSE SYSTEMIC Serious: Allergic reaction; blood in urine; chest pain; loss of appetite, EFFECTS nausea; fever, chills, new or worsening numbness; seizures, confusion, changes in mood or behavior; yellowing of skin or eyes. Less Serious: Acne, excess hair growth, headache, joint pain, muscle ache, runny or stufrfy nose; stomach upset, diarrhea, constipation; swelling or bleeding gums; tremors. CHRONIC (CANCER) NTP – Yes INFORMATION IARC – YES
